Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013


Pharmaceutical Sales & Brand Management Conference

08 Jul 2013 - 09 Jul 2013 - Las Vegas, NV , USA



Bookmark and Share


How does the pharmaceutical salesperson of the future delivery value?

The answer is no longer simple. What was once a standard operating procedure has been thrown into flux. The market is in the midst of a sea change and pharmaceutical companies are now re-evaluating brand & life cycle management, sales team design & incentives, physician & payer relationships and social media campaigns. Decisions made on these strategic issues will have a direct impact on the organization’s ability to grow as a brand.

However significant change brings new opportunity. The best strategic plans will chart new courses and create new market leaders. Sales teams of the future will solidify new bonds with customers driving brand value. New marketing campaigns will harness the voice of the customer to enhance public awareness. Access will be created by satisfying needs. But only those who understand this dynamic market and develop the best strategic tools will enjoy the successes this new future holds.

GTC’s Pharmaceutical Sales & Brand Management Conference assembles key strategic leaders to discuss and bring clarity to a transitioning market. They will discuss issues, including:
  
  · Incentivizing sales teams
  · Selling to managed care systems
  · Healthcare reform
  · Market access
  · Social media campaigns
  · Managing specialty drugs
  · Biologic strategies
  · ACOs and their relationships with pharma

This is a unique opportunity to hear from and network with your peers in an exclusive setting devoted entirely to pharmaceutical sales, marketing and brand management.


2013 Pharmaceutical Sales & Brand Management Conference Committee

Conference Advisory Board Members:
Dan Brennan, Vice President, Neurology,
 Lundbeck
Dan Camardo, Senior Director, Marketing Operations,
 Astellas Pharma US
Frank Dolan, Director, Synergy Sales Force,
 Amylin Pharmaceuticals
Christine Fiore, Compliance Business Partner, Commercial Compliance,
 Boehring Ingelheim
John Grano, Vice President, Global Sales & Marketing Effectiveness,
 Sanofi Pasteur
Kari K. Loeser, Compliance Counsel,
 Jazz Pharmaceuticals
Tom McCann, Vice President, Oncology Sales and Marketing,
 Accredo, a Division of Express Scripts

We look forward to seeing you at the conference!
 



Further information
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!